Browse drugs

…y bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.…

…ren with acute respiratory infections (WCI=0.131) and receiving oral rehydration salts and zinc for diarrhoea (WCI=0.127) showed pro-urban non-poor in…

…e other died suddenly, at home, and had been non-compliant with warfarin.Abstract 1-015 Figure 1Conclusion In a typical TV IE patient gr…

… rose from 11% to 25%. There was also an increase in the use of colchicine from 28% to 58%.The ESC guidelines recommend (grade 1B recommen…

…n should be extremely judicious, with perhaps a greater role of anti-arrhythmic drugs and pace-and-ablate.References Maron B, Maron M, Olivotto I. Br…

…cance of a coronary stenosis but requires the administration of adenosine. However, resting full-cycle ratio (RFR) is a newer, non-hypera…

…ral courses of oral antibiotics earlier and has been started on intravenous antibiotics for 6 weeks, with a plan for surgical intervention. He is to un…

… in particular the sodium-glucose co-transporter inhibitors and glucagon-like polypeptide-1 receptor agonists, which have demonstrated composite renal outcome benefit in rec…

…nhibitors), Sodium-glucose co-transporter-2 (SGLT2) inhibitors, Sacubitril/valsartan in either cohort of patients was not.Conclusion Despite a relat…

…better standardisation. Over half referred with possible HF and BNP >400 ng/l had a non-HF diagnosis, highlighting challenges in tr…

… days is similar to the difference in weight loss reported with hydrochlorothiazide plus loop diuretic compared to loop diuretic alone in the CLORO…

…s/ ARB 71.4% vs. 78.23%, p<0.001; MRA 19.3% vs. 22.1%, p<0.001; Beta blocker 79.1% vs. 86%, p<0.001; SGLT2i 3.3% vs. 7.5%, p<0.001. At 1 yea…